FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

This study has been completed.

Study NCT00053963 Information provided by National Cancer Institute (NCI)

First Received: February 5, 2003 Last Updated: December 28, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	February 2006 (Final data collection date for primary outcome measure)

Publications:

Children's Oncology Group; Fouladi M, Furman WL, Chin T, Freeman BB 3rd, Dudkin L, Stewart CF, Krailo MD, Speights R, Ingle AM, Houghton PJ, Wright J, Adamson PC, Blaney SM. Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report. J Clin Oncol. 2006 Aug 1;24(22):3678-85.

Fouladi M, Furman WL, Chin T, et al.: A phase I trial of depsipeptide in children with refractory solid tumors: a Children's Oncology Group study. [Abstract] J Clin Oncol 23 (Suppl 16): A-8528, 807s, 2005.